Outcomes of the study groups after emergent CD
c-STC group (n=592)
i-STC group (n=701)
Odds Ratio (95% Confidence Interval)
P-value
SSI rate, n (%) 19 (3.2) 38 (5.4) 1.68 (1.17-2.24) 0.031
Re-admission within 6 weeks for SSI, n (%) 9 (1.5) 27 (3.8) 2.53 (1.75-3.49) 0.023
Maternal fever, n ‎‎(%)‎ 31 (5.2) 68 (9.7) 1.87 (1.26-2.41) 0.035
Duration of maternal ‎fever, days,‎ mean ± SD 3.4 ± 2.4 3.8 ± 2.3 1.11 (1.02-3.15) 0.002
Antibiotic use, n (%)‎ 25 (4.2) 48 (6.8) 1.62 (1.21-2.27) 0.044
Duration of ‎antibiotic use, days,‎ mean ± SD 8.3 ± 3.5 7.9 ± 4.1 1.05 (0.41-3.11) 0.59
CD-to-SSI time interval‎ days,‎ mean ± SD 2.4 ± 2.1 2.5 ± 2.2 1.04 (0.13-5.16) 0.38
Bacteremia and / or sepsis, n (%)‎ 7 (1.2) 10 (1.4) 1.16 (0.72-1.48) 0.24
Post-op hospitalization duration, days, ‎mean ± SD‎ 4.4 ± 2.5 5.3 ± 2.6 1.21 (0.39-4.15) <0.0001